This protocol is designed to study Orthofix regulatory approved and commercially available spine devices to generate Real World Evidence (RWE) of device safety and performance in the treatment of patients with spine injuries and/or disorders following the local medical standard of care. The clinical data generated from this study will support compliance to global regulatory requirements including but not limited to the European Medical Device Regulation (EU MDR) for the applicable devices.
Spinal Disorders/Injuries
This protocol is designed to study Orthofix regulatory approved and commercially available spine devices to generate Real World Evidence (RWE) of device safety and performance in the treatment of patients with spine injuries and/or disorders following the local medical standard of care. The clinical data generated from this study will support compliance to global regulatory requirements including but not limited to the European Medical Device Regulation (EU MDR) for the applicable devices.
A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices
-
Lanman Spinal Neurosurgery, Beverly Hills, California, United States, 90210
RasouliSpine, Beverly Hills, California, United States, 90211
Neurosurgical Medical Clinic, San Diego, California, United States, 92111
Acadiana Neurosurgery, Lafayette, Louisiana, United States, 70508
Columbus Orthopaedic, Columbus, Mississippi, United States, 39705
M3 Emerging Medical Research, Durham, North Carolina, United States, 27704
University Orthopedics, East Providence, Rhode Island, United States, 02914
Summit Brain, Spine and Orthopedics, Lehi, Utah, United States, 84043
Tuckahoe Orthopedics, Richmond, Virginia, United States, 23226
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Orthofix Inc.,
Cahit Akbas, STUDY_DIRECTOR, Global Clinical Program Manager
2031-12